Akero Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2018-12-18: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2018-12-10; Total offering amount $45,499,989.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2018-12-18 | Rule 506(b) | Equity | 2018-12-10 | $45,499,989 | $45,499,989 | $0 | 20 |